OBJECTIVE: To determine the prevalence of fathers' attendance at pretest cancer genetic counseling sessions with mothers undergoing BRCA1/2 genetic testing for hereditary breast/ovarian cancer (HBOC) risk, and to identify psychosocial and other correlates of fathers' attendance. METHODS: One hundred and twenty-one fathers of minor-age children who were spouses/partners of women (mothers) undergoing such counseling and testing were recruited, completed a behavioral self-report survey, and provided data about their sociodemographic backgrounds, father-child cancer communication histories, parenting relationship quality, and information-seeking and perceived knowledge. RESULTS: A total of 27.3% of fathers attended pretest cancer genetic counseling with mothers. Compared to fathers who did not attend pretest cancer genetic counseling, those who did had stronger parenting alliances with mothers, were more likely to have sought out information about BRCA1/2 testing, and felt more informed about testing. In an adjusted logistic regression model of session attendance, the strength of the parenting alliance was associated with a 6% increase in the likelihood of attending genetic counseling (odds ratio [OR]=1.06, 95% confidence interval [CI]=1.01, 1.12, p<.05) and greater perceived knowledge about BRCA1/2 testing was associated with a four-fold increase in the likelihood of session attendance (OR=4.03, CI=1.77, 9.37, p<.001). CONCLUSION: One in three fathers attend pretest cancer genetic counseling with mothers undergoing BRCA1/2 testing; those who do have closer parenting relationships and are more informed about BRCA1/2 testing. PRACTICE IMPLICATIONS: When possible, providers should discuss mothers including fathers in cancer genetic counseling sessions as this may affect outcomes of HBOC genetic counseling and testing.
OBJECTIVE: To determine the prevalence of fathers' attendance at pretest cancer genetic counseling sessions with mothers undergoing BRCA1/2 genetic testing for hereditary breast/ovarian cancer (HBOC) risk, and to identify psychosocial and other correlates of fathers' attendance. METHODS: One hundred and twenty-one fathers of minor-age children who were spouses/partners of women (mothers) undergoing such counseling and testing were recruited, completed a behavioral self-report survey, and provided data about their sociodemographic backgrounds, father-childcancer communication histories, parenting relationship quality, and information-seeking and perceived knowledge. RESULTS: A total of 27.3% of fathers attended pretest cancer genetic counseling with mothers. Compared to fathers who did not attend pretest cancer genetic counseling, those who did had stronger parenting alliances with mothers, were more likely to have sought out information about BRCA1/2 testing, and felt more informed about testing. In an adjusted logistic regression model of session attendance, the strength of the parenting alliance was associated with a 6% increase in the likelihood of attending genetic counseling (odds ratio [OR]=1.06, 95% confidence interval [CI]=1.01, 1.12, p<.05) and greater perceived knowledge about BRCA1/2 testing was associated with a four-fold increase in the likelihood of session attendance (OR=4.03, CI=1.77, 9.37, p<.001). CONCLUSION: One in three fathers attend pretest cancer genetic counseling with mothers undergoing BRCA1/2 testing; those who do have closer parenting relationships and are more informed about BRCA1/2 testing. PRACTICE IMPLICATIONS: When possible, providers should discuss mothers including fathers in cancer genetic counseling sessions as this may affect outcomes of HBOC genetic counseling and testing.
Authors: I van Oostrom; H Meijers-Heijboer; H J Duivenvoorden; A H J T Bröcker-Vriends; C J van Asperen; R H Sijmons; C Seynaeve; A R van Gool; J G M Klijn; A Tibben Journal: Clin Genet Date: 2007-01 Impact factor: 4.438
Authors: Iris van Oostrom; Hanne Meijers-Heijboer; Hugo J Duivenvoorden; Annette H J T Bröcker-Vriends; Christi J van Asperen; Rolf H Sijmons; Caroline Seynaeve; Arthur R Van Gool; Jan G M Klijn; Aad Tibben Journal: Patient Educ Couns Date: 2006-07-26
Authors: Angela R Bradbury; Linda Patrick-Miller; Kimberly Pawlowski; Comfort N Ibe; Shelly A Cummings; Fay Hlubocky; Olufunmilayo I Olopade; Christopher K Daugherty Journal: Psychooncology Date: 2009-02 Impact factor: 3.894
Authors: Darren Mays; Tiffani A DeMarco; George Luta; Beth N Peshkin; Andrea F Patenaude; Katherine A Schneider; Judy E Garber; Kenneth P Tercyak Journal: Health Psychol Date: 2013-06-24 Impact factor: 4.267
Authors: McKane E Sharff; Tiffani A DeMarco; Darren Mays; Beth N Peshkin; Heiddis B Valdimarsdottir; Judy E Garber; Katherine A Schneider; Andrea F Patenaude; Kenneth P Tercyak Journal: Genet Test Mol Biomarkers Date: 2011-11-15
Authors: Kenneth P Tercyak; Darren Mays; Tiffani A DeMarco; McKane E Sharff; Susan Friedman Journal: J Med Internet Res Date: 2012-01-18 Impact factor: 5.428